New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Experts advise against routine testing for prostate cancer

Experts advise against routine testing for prostate cancer

by British Medical JournalMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Routine testing for prostate cancer is n
Oncology April 07,2024
Experts advise against routine testing for prostate cancer

Experts advise against routine testing for prostate cancer

by British Medical JournalMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Routine testing for prostate cancer is n
Oncology April 07,2024
Shot could remove side effects from late-stage head and neck cancer therapy

Shot could remove side effects from late-stage head and neck cancer therapy

by Kayla Wiles,Purdue UniversityCredit: CC0 Public DomainFor advanced stages of head and neck cancer, one of the best treatments is so aggressive that it could bring tooth decay, speech loss, co
Oncology April 07,2024
Shot could remove side effects from late-stage head and neck cancer therapy

Shot could remove side effects from late-stage head and neck cancer therapy

by Kayla Wiles,Purdue UniversityCredit: CC0 Public DomainFor advanced stages of head and neck cancer, one of the best treatments is so aggressive that it could bring tooth decay, speech loss, co
Oncology April 07,2024
Experts call for a targeted approach to cancer prevention

Experts call for a targeted approach to cancer prevention

by University of StirlingCredit: CC0 Public DomainPolicymakers around the world should consider introducing more targeted early interventions in a bid to tackle cancer, according to experts at th
Oncology April 07,2024
Experts call for a targeted approach to cancer prevention

Experts call for a targeted approach to cancer prevention

by University of StirlingCredit: CC0 Public DomainPolicymakers around the world should consider introducing more targeted early interventions in a bid to tackle cancer, according to experts at th
Oncology April 07,2024
Area surrounding a tumor impacts how breast cancer cells grow

Area surrounding a tumor impacts how breast cancer cells grow

by Amanda Gibbs,Oregon Health & Science University“Cancer is acomplex mixture of cancer cells, normal blood cells, tissue and immune cells. Tumor cells themselves alter the microenviro
Oncology April 07,2024
Area surrounding a tumor impacts how breast cancer cells grow

Area surrounding a tumor impacts how breast cancer cells grow

by Amanda Gibbs,Oregon Health & Science University“Cancer is acomplex mixture of cancer cells, normal blood cells, tissue and immune cells. Tumor cells themselves alter the microenviro
Oncology April 07,2024
New discoveries in circadian rhythms provide insight into cancer treatment

New discoveries in circadian rhythms provide insight into cancer treatment

by Tiffany Trent,Virginia TechCarla Finkielstein shares notes with visiting student Xianlin Zou. Credit: Virginia TechIn a recent paper inScience Signaling, associate professor of cell and
Oncology April 07,2024
New discoveries in circadian rhythms provide insight into cancer treatment

New discoveries in circadian rhythms provide insight into cancer treatment

by Tiffany Trent,Virginia TechCarla Finkielstein shares notes with visiting student Xianlin Zou. Credit: Virginia TechIn a recent paper inScience Signaling, associate professor of cell and
Oncology April 07,2024
Formation of new blood vessels in tumors regulated by p38 protein

Formation of new blood vessels in tumors regulated by p38 protein

by Institute for Research in Biomedicine (IRB Barcelona)Structure of a blood vessel. Credit: Raquel Batlle, IRB BarcelonaA study performed at the Institute for Research in Biomedicine(IRB Barcelo
Oncology April 07,2024
Formation of new blood vessels in tumors regulated by p38 protein

Formation of new blood vessels in tumors regulated by p38 protein

by Institute for Research in Biomedicine (IRB Barcelona)Structure of a blood vessel. Credit: Raquel Batlle, IRB BarcelonaA study performed at the Institute for Research in Biomedicine(IRB Barcelo
Oncology April 07,2024
Repurposing existing FDA-approved inhibitors may provide new treatment approach for ovarian cancer

Repurposing existing FDA-approved inhibitors may provide new treatment approach for ovarian cancer

by The Wistar InstituteCredit: The Wistar InstituteWistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for t
Oncology April 07,2024
Repurposing existing FDA-approved inhibitors may provide new treatment approach for ovarian cancer

Repurposing existing FDA-approved inhibitors may provide new treatment approach for ovarian cancer

by The Wistar InstituteCredit: The Wistar InstituteWistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for t
Oncology April 07,2024
Tumor mutations may predict response to immunotherapy

Tumor mutations may predict response to immunotherapy

by Johns Hopkins University School of MedicineMismatch repair deficiency refers to a characteristic of some cancer cells that create a large number of mutations, or changes, in certain genes when
Oncology April 07,2024
Tumor mutations may predict response to immunotherapy

Tumor mutations may predict response to immunotherapy

by Johns Hopkins University School of MedicineMismatch repair deficiency refers to a characteristic of some cancer cells that create a large number of mutations, or changes, in certain genes when
Oncology April 07,2024
Race/ethnicity, socioeconomics, age contribute to disparities in cancer death

Race/ethnicity, socioeconomics, age contribute to disparities in cancer death

by Elana GotkineFactors contributing to disparities in cancer death include race/ethnicity, socioeconomic status, geographic location, and age, according to a study published online Nov. 14 inCA
Oncology April 07,2024
Race/ethnicity, socioeconomics, age contribute to disparities in cancer death

Race/ethnicity, socioeconomics, age contribute to disparities in cancer death

by Elana GotkineFactors contributing to disparities in cancer death include race/ethnicity, socioeconomic status, geographic location, and age, according to a study published online Nov. 14 inCA
Oncology April 07,2024
Tumor suppressor gene variants identified as cancer 'double whammy' for leukemia patients

Tumor suppressor gene variants identified as cancer 'double whammy' for leukemia patients

by St. Jude Children's Research HospitalJun J. Yang, Ph.D., identified 22 high-risk germline variations associated with high-risk acute lymphoblastic leukemia that increases risk of relapse o
Oncology April 07,2024
Tumor suppressor gene variants identified as cancer 'double whammy' for leukemia patients

Tumor suppressor gene variants identified as cancer 'double whammy' for leukemia patients

by St. Jude Children's Research HospitalJun J. Yang, Ph.D., identified 22 high-risk germline variations associated with high-risk acute lymphoblastic leukemia that increases risk of relapse o
Oncology April 07,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com